The COVID-19 outbreak in South Korea has risen again recently. The health department believes that the risk of infection is much lower than when the epidemic was rampant, so there is no need to adjust the response level, but plans to expand the supply of treatment drugs. Sun Yinglai, director of the Infectious Disease Crisis Management Bureau of the Korea Centers for Disease Control and Prevention, said at a press conference on the 12th that the COVID-19 outbreak is spreading again, and the number of confirmed cases is likely to continue to increase in the future, but the mortality rate is less than 0.1%, and the risk of the disease has been greatly reduced. He said that the current response mechanism is not a big deal, so there is no need to adjust the response level. South Korea lowered the COVID-19 response level to the lowest level of "concern" in May this year. In addition, the CDC plans to expand the supply of COVID-19 treatment drugs. In July, the CDC provided 76,043 doses of treatment drugs to health stations, pharmacies, etc. in cities and provinces across the country, an increase of about 42 times and 103 times compared to May and June, respectively. Sun Yinglai said that the government has begun to purchase additional treatment drugs and plans to put them on the market within this month.